Log in to save to my catalogue

360 The comparison between chemiluminescent immunoassay and line immunoassay for the detection of an...

360 The comparison between chemiluminescent immunoassay and line immunoassay for the detection of an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1880697637

360 The comparison between chemiluminescent immunoassay and line immunoassay for the detection of antibodies specific to sle diagnosis: a randomised, independent multi-centre clinical study in china

About this item

Full title

360 The comparison between chemiluminescent immunoassay and line immunoassay for the detection of antibodies specific to sle diagnosis: a randomised, independent multi-centre clinical study in china

Author / Creator

Publisher

London: BMJ Publishing Group LTD

Journal title

Lupus science & medicine, 2017-03, Vol.4 (Suppl 1), p.A158

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Background and aimsAutoantibodies to Sm, dsDNA, Nucleosome (Nuc) and Ribosome P protein (Rib-P) are highly specific to Systemic Lupus Erythematosis (SLE) diagnosis. We aimed to compare Chemiluminescent immunoassay (CLIA) platform (BioCLIA 1200) and Line ImmunoAssay (LIA) on the conformational detection of these SLE specific antibodies through a ran...

Alternative Titles

Full title

360 The comparison between chemiluminescent immunoassay and line immunoassay for the detection of antibodies specific to sle diagnosis: a randomised, independent multi-centre clinical study in china

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1880697637

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1880697637

Other Identifiers

E-ISSN

2053-8790

DOI

10.1136/lupus-2017-000215.360

How to access this item